Clinical application: Brain nerve damage

S100-β protein, as a neurospecific serum marker, is highly specific for the assessment of central nervous system vascular diseases, and can be used as a predictor of the severity and prognosis of cerebrovascular-related diseases. The detection of S100-β protein concentration in serum and cerebrospinal fluid can be used as a laboratory indicator for secondary brain injury and prognosis assessment, and can provide reference for clinical timely and effective medical intervention.

Bedside cranial nerve injury detection project of LEHE：S100-β

By detecting the concentration of serum S100-β protein, it can reflect the severity and prognosis of brain tissue injury and the integrity of blood-brain barrier.

Disease

Clinical application

LEHE Products

1. ?Ischemic stroke

2. Cerebral hemorrhage

3. Subarachnoid hemorrhage

1. Assess the severity of brain damage, predict the size and prognosis of ischemic stroke

S100-β

2. An indicator of early neurological deficits to assess vascular diseases of the central nervous system